Dr. Reddy’s Laboratories has informed that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company has approved the allotment of 13,080 equity shares of Re.1/- each of the Company, fully paid up, on December 19, 2024, to employees pursuant to exercise of their Stock Options, as per the following details: a) 13,080 equity shares of Re.1/- each pursuant to Dr. Reddy’s Employees Stock Options Scheme, 2002. Further, it has enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1619.70 |
| Dr. Reddys Lab | 1331.25 |
| Cipla | 1289.40 |
| Zydus Lifesciences | 930.55 |
| Lupin | 2270.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: